CME Group, a global derivatives marketplace, has appointed Laurent Paulhac to its management team as managing director, Over-the-Counter (OTC) products and services. He will report to Rick Redding, managing director, products & services.
Mr. Paulhac will be responsible for leading the development, execution and management of CME Group’s global OTC business strategy. He will be based in New York.
Mr. Paulhac previously served as CEO of CMA, a provider of credit derivatives market data acquired by CME Group in 2008. However, he will continue to lead the CMA organization for a transition period until a new CEO is appointed.
Reportedly, through CME ClearPort, CME Group offers OTC market participants a set of clearing services to mitigate counter party risk and provide neutral valuations across asset classes.
Mr. Redding said: “Mr. Laurent’s experience in credit and interest rate products will be a tremendous asset to CME Group as we broaden our OTC offerings and focus on delivering cleared-only solutions to our OTC clients around the world through CME ClearPort.”
